Livemedia Home

Previous Events


Next Events

facebook_icon twitter_icon youtube_icon google_plus_icon instagram rss_icon

 Login / Register to Livemedia



Forgot your password?

A+ | A-
GR | EN

10/03/2017 Congresses | Video | 9th International Congress of Internal Medicine | C.Yurdaydin | Chronic hepatitis delta: An update

 
307 VIEWS EXPANDCOLLAPSE Presentation

Share

74.525 total
8 live
307 video
38.228 photo
Views:

10:00-11:30 ROUND TABLE
Πρόεδροι: S.Hadziyannis ,J.Koskinas
10:00-10:25 Chronic hepatitis B: Discontinuation of oral antivirals
S.Hadziyannis
10:25-10:50 Chronic hepatitis C: Challenges in special populations
H.Wedemeyer
10:50-11:15 Chronic hepatitis delta: An update
C.Yurdaydin
11:15-11:30 Discussion


 
Sort by Date | Views

Watch On Demand: 9th International Congress of Internal Medicine

Dates: March 9-11, 2017
Venue: Hilton Athens Hotel,Athens, Greece
Organization: Institute of Internal Medicine & Hepatology, Larissa, Greece

Department of Medicine & Research Laboratory of Internal Medicine
University of Thessaly Medical School, Larissa, Greece

Director: Professor G.N. Dalekos

Under the auspices of: University of Thessaly Medical School, Larissa, Greece
Website: www.internalmedicine-uth.gr

For the program, please click here.

P. Mallis | ORAL PRESENTATIONS OP01-OP09 490
E, Sevim | ORAL PRESENTATIONS OP01-OP09 339
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 341
V. Papavasileiou | ORAL PRESENTATIONS OP01-OP09 311
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 382
G. Ntaios | ORAL PRESENTATIONS OP01-OP09 302
S. O. Serin | ORAL PRESENTATIONS OP01-OP09 316
G. Ntetskas | ORAL PRESENTATIONS OP01-OP09 285
R.Liberal | Importance of European registries... 327
C.Packard | Should we treat everyone above... 607
K.Hovingh | Familial hypercholesterolemia... 539
T.Pedersen | PCSK9 inhibition: What is hot... 444
M.Burnier | Pros 346
K. P. Makaritsis Cons 399
Discussion - Questions 248
682
J.Putaala | Stroke in the young 344
J.Ferro | Drug-induced stroke 357
D.Strbian | Can we predict thrombolysis-associated... 344
C.Weimar | Management of intracranial artery... 339
Gk. Katsifis | SATELLITE LECTURE Sponsored... 435
H.Mattle | Patent foramen ovale in cryptogenic... 355
G. N. Dalekos | Welcome 308
Vravefsi | OPENING CEREMONY 236
D.Sereni | Inaugural Lecture 279
M Papatheodoridi | ORAL PRESENTATIONS OP10-OP18 405
S. Savvanis | ORAL PRESENTATIONS OP10-OP18 263
V. Ligoyra | ORAL PRESENTATIONS OP10-OP18... 237
K. Azariadi | ORAL PRESENTATIONS OP10-OP18... 251
I. Mani | ORAL PRESENTATIONS OP10-OP18 274
S. Karatapanis | ORAL PRESENTATIONS OP10-OP18 218
P. Arvaniti | ORAL PRESENTATIONS OP10-OP18 283
A. Molyvdas | ORAL PRESENTATIONS OP10-OP18 271
T. Karaoulani | ORAL PRESENTATIONS OP10-OP18 249
H.Toplak | Epidemiology, definition and... 317
P.Nilsson | Obesity, impaired glucose metabolism... 351
V.Kotsis | Mechanisms of obesity induced... 380
J. Jordan | Novel drugs in the treatment... 354
H.Wedemeyer | Chronic hepatitis C: Challenges... 319
Q&A | ROUND TABLE 278
C.Yurdaydin | Chronic hepatitis delta: An... 307
L.Guillevin | Treatment of ANCA-associated... 348
M.Rizzo | Novel approaches to manage dyslipidaemia,... 347
M.Samson | Biological-targeted treatments... 334
P.Valensi | Silent myocardial ischaemia... 256
Y.Renaudineau | Primary Sjögren’s syndrome:... 313
D.Ziegler | Diabetic neuropathy: New developments... 267
Q & A | ROUND TABLE 338
M.Manoussakis | Axial spondyloarthritis... 333
N. Gatselis | SATELLITE LECTURE 320
M. Mela | SATELLITE LECTURE 271
K. Mimidis | SATELLITE LECTURE 202
Q & A | SATELLITE LECTURE 274
F.Menichetti | Choosing antibiotics in difficult... 503
G. N. Dalekos | SATELLITE SYMPOSIUM 374
N Sipsas | SATELLITE SYMPOSIUM 299
R.Pálsson | European Curriculum of Internal... 345
N.Montano | Choosing wisely: To be or not... 289
P.Mannucci | The role of EFIM publications... 356
G.Lip | Selecting the appropriate antithrombotic... 316
E. Rapti | SATELLITE SYMPOSIUM 1.277
M. Schina | SATELLITE SYMPOSIUM 226
M. Bosilkovski | ORAL PRESENTATIONS OP28-OP33 391
S. Thomson | ORAL PRESENTATIONS OP28-OP33 240
M. Grira | ORAL PRESENTATIONS OP28-OP33 396
J. A. Lopes | Definition, classification... 404
D.Menucci | The role of points of entry... 327
R.Pálsson | Acute kidney injury after abdominal... 347
T.Hofmann | The impact of the International... 281
Q & A | ROUND TABLE 256
D. Vergani | STATE OF THE ART LECTURE 271
H.van Buuren | Scientific and practical... 322
A.Floreani | PBC: Old and novel therapies 272
A.Parés | Variant syndromes: Classification... 325
G.Hirschfield | Deranged cholestatic enzymes... 283
M.Blank | Disease specific IVIG to treat... 338
N. Gatselis | SATELLITE LECTURE 301
M.Ekstedt | Steatosis and metabolic risk... 287
E.Tsochatzis | Non-invasive assessment of... 323
P.Montravers | Reducing the antifungal drugs... 274
Q.Anstee | NAFLD genetics 267
M.Akova | Fighting multi-drug resistant... 327
P.Mannucci | The coagulopathy of chronic... 291
Y.de Boer | Diagnostic evaluation of suspected... 369
A.Alexopoulou | Management and outcome of... 407
C.Marañón | Myeloid populations are altered... 281
G. Papatheodoridis - Current challenges in... 366
S. Manolakokpoulos - New possibilities for... 321
I. Goulis - New combination EBR/GZR: the... 259
I. Vlachogiannakos - Next generation DAAs:... 245
Q & A | SATELLITE SYMPOSIUM 242
A. Floreani | Interview 546
1:10
R. Liberal | Interview 327
1:13
Y. de Boer | Interview 296
0:20